A fund that holds the private companies you cannot buy

Ark Venture, trading under the ticker ARKVX, is Cathie Wood’s closed-end interval fund, and it is one of two vehicles Alexander Green names as the backdoor to the Anthropic IPO in his “Secret Backdoor to the REAL #1 Tech IPO of 2026” presentation. The appeal is straightforward: ARKVX holds a basket of private technology companies that retail investors cannot buy directly, including Anthropic, SpaceX, and OpenAI. Green describes it as a free ticket to the IPO, which is an optimistic framing worth examining closely.

The fund is not a pure play on Anthropic. Anthropic is roughly 4.3 percent of ARKVX, its fourth-largest position, and OpenAI is actually a larger holding. SpaceX and a wider set of private names fill out the rest. So when you buy ARKVX, you are buying a diversified private-tech portfolio, not a concentrated bet on the Claude maker.

How the structure actually works

The structure of ARKVX is the most important thing to understand, because it differs from a normal ETF or mutual fund in ways that affect when you can get your money back. ARKVX is an interval fund, which means it only allows redemptions on a fixed schedule. Investors can redeem at most 5 percent of the fund per quarter, a cap that protects the fund from having to sell illiquid private holdings at bad times but also limits your exit.

The fund prices at net asset value rather than at a market premium, which is a genuine advantage over its sibling in Green’s pitch. Fundrise Venture, the closed-end fund trading as VCX, trades around $41 against an estimated NAV of $25 to $30. ARKVX avoids that premium entirely because it is priced on its NAV rather than on exchange supply and demand. For a side-by-side comparison, see our Anthropic stock guide.

The cost of admission

The trade-off for NAV pricing is cost and friction. ARKVX carries a 2.9 percent annual fee, which is high by the standards of index funds and eats into returns every year regardless of performance. There is also a $500 minimum investment, which is low enough for most retail investors but still a barrier for some. Combined with the quarterly 5 percent redemption cap, the fund asks you to accept less flexibility in exchange for access to assets you could not otherwise buy.

That is not a criticism of the fund so much as a description of how it works. Private-company exposure always comes with some combination of premium, fees, or lockup, and ARKVX has chosen fees and redemption limits over a market premium. Whether that trade-off suits you depends on your timeline and your tolerance for illiquidity.

The free ticket, examined

Green’s phrase “free ticket” is a rhetorical flourish, not a literal description. There is no free access to Anthropic through ARKVX. You pay a 2.9 percent fee, you accept redemption limits, and your Anthropic exposure is diluted across a portfolio where OpenAI and SpaceX are just as prominent. None of that makes the fund a bad product, and Cathie Wood’s team has a long record of running thematic portfolios. It simply means the honest framing is that ARKVX is a reasonably priced but frictional way to own a slice of the private AI economy, not a free pass into a single IPO.

For the other side of the coin, the fund that does concentrate on Anthropic, see our Claude AI stock explainer. And for how SpaceX fits into the same pre-IPO enthusiasm, our SpaceX IPO piece covers a parallel story.

The bottom line

ARKVX is a legitimate vehicle with a real holding in Anthropic, and it is the more honestly priced of Green’s two backdoor options. The 2.9 percent fee, the $500 minimum, and the quarterly redemption caps are the price of that honesty. Investors who want private-tech exposure and can accept the illiquidity may find it a reasonable fit. Investors who want a concentrated, low-friction Anthropic bet will be disappointed by how diluted the position is. Either way, the fund deserves to be understood on its own terms rather than through the lens of a free ticket.

How ARKVX sits in the broader Ark lineup

ARKVX is part of Cathie Wood’s wider family of thematic funds, most of which trade on exchanges as ETFs with daily liquidity. ARKVX is different by design: it is an interval fund because it holds private companies that cannot be sold on demand, and the quarterly redemption cap is the price of that access. Investors who are used to the daily liquidity of an ETF should understand that ARKVX is a different instrument before they buy it.

The honest bottom line

ARKVX is a legitimate, reasonably priced way to hold a slice of the private AI economy, and its NAV pricing is the cleanest feature of the two funds Green names. But it is not free, it is not concentrated on Anthropic, and it is not liquid in the way a normal fund is. The 2.9 percent fee, the $500 minimum, and the 5 percent quarterly redemption cap are the real terms of the deal. An investor who accepts those terms gets genuine exposure; an investor who expects a free pass into a single IPO will be disappointed.

Ready to see the research? Click here to access Alexander Green’s report.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.